- Home
- CCIF vs PYXS Comparison
CCIF vs PYXS Comparison
Compare CCIF & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- PYXS
- Stock Information
- Founded
- CCIF 2011
- PYXS 2018
- Country
- CCIF United States
- PYXS United States
- Employees
- CCIF N/A
- PYXS N/A
- Industry
- CCIF Finance/Investors Services
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- CCIF Finance
- PYXS Health Care
- Exchange
- CCIF Nasdaq
- PYXS Nasdaq
- Market Cap
- CCIF 110.5M
- PYXS 101.1M
- IPO Year
- CCIF N/A
- PYXS 2021
- Fundamental
- Price
- CCIF $7.90
- PYXS $1.50
- Analyst Decision
- CCIF
- PYXS Strong Buy
- Analyst Count
- CCIF 0
- PYXS 8
- Target Price
- CCIF N/A
- PYXS $9.43
- AVG Volume (30 Days)
- CCIF 76.9K
- PYXS 817.5K
- Earning Date
- CCIF 01-01-0001
- PYXS 11-12-2024
- Dividend Yield
- CCIF 25.90%
- PYXS N/A
- EPS Growth
- CCIF N/A
- PYXS N/A
- EPS
- CCIF N/A
- PYXS N/A
- Revenue
- CCIF N/A
- PYXS $16,146,000.00
- Revenue This Year
- CCIF N/A
- PYXS N/A
- Revenue Next Year
- CCIF N/A
- PYXS N/A
- P/E Ratio
- CCIF N/A
- PYXS N/A
- Revenue Growth
- CCIF N/A
- PYXS N/A
- 52 Week Low
- CCIF $7.43
- PYXS $1.39
- 52 Week High
- CCIF $10.16
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- CCIF 45.64
- PYXS 36.16
- Support Level
- CCIF $7.62
- PYXS $1.39
- Resistance Level
- CCIF $8.06
- PYXS $1.82
- Average True Range (ATR)
- CCIF 0.13
- PYXS 0.10
- MACD
- CCIF -0.00
- PYXS 0.03
- Stochastic Oscillator
- CCIF 64.63
- PYXS 25.58
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.